In contrast, Bonavita et al. [33] recently reported the epigenetic repression of PTX3 via the promoter region in selected human cancers such as leiomyosarcoma and colorectal cancer, thereby proposing that PTX3 serves as an extrinsic oncosuppressor that restrains complement-dependent tumor-promoting inflammation. Here, PTX3 is linked to colorectal cancer.